Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy to improve viability detection

Rosa Sicari, Albert Varga, Eugenio Picano, Adrian C. Borges, Alessia Gimelli, Paolo Marzullo

Research output: Contribution to journalArticle

Abstract

The aim of this study was to investigate the relation between radioisotopic and echocardiographic markers of myocardial viability and their correlation with functional recovery after coronary revascularization. Myocardial viability can be detected by techniques exploring various aspects of cell physiology: thallium-201 scintigraphy and dobutamine and dipyridamole echocardiography focus on cell membrane integrity, β-1 and adrenoceptor, and A2-adenosine receptor-mediated inotropic response, respectively. Fifty-seven patients (mean age 60 ± 8 years) with previous myocardial infarction (>3 months), angiographically assessed coronary artery disease, and resting regional dysfunction underwent rest-redistribution 201-thallium scintigraphy and low-dose pharmacologic stress echo with dobutamine (up to 10 μg/kg/min), very low dose regimen of dipyridamole (0.28 mg/kg over 4 minutes), and combined dipyridamole-dobutamine. Criteria for viability in a 13-segment model for both techniques were percent peak activity in redistribution images >55% for thallium-201 and a decrease in wall motion score >1 grade (1 [normal] to 4 [dyskinetic]) for stress echo. Thirty patients underwent coronary revascularization (bypass surgery in 8, angioplasty in 22) and were followed up at 4 weeks from intervention with a resting echocardiogram. The rate of agreement between thallium-201 and stress echo was 63% for dipyridamole, 66% for dobutamine, and 74% for combined dipyridamole- dobutamine (p

Original languageEnglish
Pages (from-to)6-10
Number of pages5
JournalThe American Journal of Cardiology
Volume83
Issue number1
DOIs
Publication statusPublished - Jan 1 1999

Fingerprint

Dobutamine
Dipyridamole
Thallium
Radionuclide Imaging
Echocardiography
Adenosine A2 Receptors
Cell Physiological Phenomena
Angioplasty
Adrenergic Receptors
Coronary Artery Disease
Myocardial Infarction
Cell Membrane

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy to improve viability detection. / Sicari, Rosa; Varga, Albert; Picano, Eugenio; Borges, Adrian C.; Gimelli, Alessia; Marzullo, Paolo.

In: The American Journal of Cardiology, Vol. 83, No. 1, 01.01.1999, p. 6-10.

Research output: Contribution to journalArticle

Sicari, Rosa ; Varga, Albert ; Picano, Eugenio ; Borges, Adrian C. ; Gimelli, Alessia ; Marzullo, Paolo. / Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy to improve viability detection. In: The American Journal of Cardiology. 1999 ; Vol. 83, No. 1. pp. 6-10.
@article{dd90a7b4bb384c72bb7d47e30de99c57,
title = "Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy to improve viability detection",
abstract = "The aim of this study was to investigate the relation between radioisotopic and echocardiographic markers of myocardial viability and their correlation with functional recovery after coronary revascularization. Myocardial viability can be detected by techniques exploring various aspects of cell physiology: thallium-201 scintigraphy and dobutamine and dipyridamole echocardiography focus on cell membrane integrity, β-1 and adrenoceptor, and A2-adenosine receptor-mediated inotropic response, respectively. Fifty-seven patients (mean age 60 ± 8 years) with previous myocardial infarction (>3 months), angiographically assessed coronary artery disease, and resting regional dysfunction underwent rest-redistribution 201-thallium scintigraphy and low-dose pharmacologic stress echo with dobutamine (up to 10 μg/kg/min), very low dose regimen of dipyridamole (0.28 mg/kg over 4 minutes), and combined dipyridamole-dobutamine. Criteria for viability in a 13-segment model for both techniques were percent peak activity in redistribution images >55{\%} for thallium-201 and a decrease in wall motion score >1 grade (1 [normal] to 4 [dyskinetic]) for stress echo. Thirty patients underwent coronary revascularization (bypass surgery in 8, angioplasty in 22) and were followed up at 4 weeks from intervention with a resting echocardiogram. The rate of agreement between thallium-201 and stress echo was 63{\%} for dipyridamole, 66{\%} for dobutamine, and 74{\%} for combined dipyridamole- dobutamine (p",
author = "Rosa Sicari and Albert Varga and Eugenio Picano and Borges, {Adrian C.} and Alessia Gimelli and Paolo Marzullo",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0002-9149(98)00773-5",
language = "English",
volume = "83",
pages = "6--10",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy to improve viability detection

AU - Sicari, Rosa

AU - Varga, Albert

AU - Picano, Eugenio

AU - Borges, Adrian C.

AU - Gimelli, Alessia

AU - Marzullo, Paolo

PY - 1999/1/1

Y1 - 1999/1/1

N2 - The aim of this study was to investigate the relation between radioisotopic and echocardiographic markers of myocardial viability and their correlation with functional recovery after coronary revascularization. Myocardial viability can be detected by techniques exploring various aspects of cell physiology: thallium-201 scintigraphy and dobutamine and dipyridamole echocardiography focus on cell membrane integrity, β-1 and adrenoceptor, and A2-adenosine receptor-mediated inotropic response, respectively. Fifty-seven patients (mean age 60 ± 8 years) with previous myocardial infarction (>3 months), angiographically assessed coronary artery disease, and resting regional dysfunction underwent rest-redistribution 201-thallium scintigraphy and low-dose pharmacologic stress echo with dobutamine (up to 10 μg/kg/min), very low dose regimen of dipyridamole (0.28 mg/kg over 4 minutes), and combined dipyridamole-dobutamine. Criteria for viability in a 13-segment model for both techniques were percent peak activity in redistribution images >55% for thallium-201 and a decrease in wall motion score >1 grade (1 [normal] to 4 [dyskinetic]) for stress echo. Thirty patients underwent coronary revascularization (bypass surgery in 8, angioplasty in 22) and were followed up at 4 weeks from intervention with a resting echocardiogram. The rate of agreement between thallium-201 and stress echo was 63% for dipyridamole, 66% for dobutamine, and 74% for combined dipyridamole- dobutamine (p

AB - The aim of this study was to investigate the relation between radioisotopic and echocardiographic markers of myocardial viability and their correlation with functional recovery after coronary revascularization. Myocardial viability can be detected by techniques exploring various aspects of cell physiology: thallium-201 scintigraphy and dobutamine and dipyridamole echocardiography focus on cell membrane integrity, β-1 and adrenoceptor, and A2-adenosine receptor-mediated inotropic response, respectively. Fifty-seven patients (mean age 60 ± 8 years) with previous myocardial infarction (>3 months), angiographically assessed coronary artery disease, and resting regional dysfunction underwent rest-redistribution 201-thallium scintigraphy and low-dose pharmacologic stress echo with dobutamine (up to 10 μg/kg/min), very low dose regimen of dipyridamole (0.28 mg/kg over 4 minutes), and combined dipyridamole-dobutamine. Criteria for viability in a 13-segment model for both techniques were percent peak activity in redistribution images >55% for thallium-201 and a decrease in wall motion score >1 grade (1 [normal] to 4 [dyskinetic]) for stress echo. Thirty patients underwent coronary revascularization (bypass surgery in 8, angioplasty in 22) and were followed up at 4 weeks from intervention with a resting echocardiogram. The rate of agreement between thallium-201 and stress echo was 63% for dipyridamole, 66% for dobutamine, and 74% for combined dipyridamole- dobutamine (p

UR - http://www.scopus.com/inward/record.url?scp=0032925440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032925440&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(98)00773-5

DO - 10.1016/S0002-9149(98)00773-5

M3 - Article

C2 - 10073776

AN - SCOPUS:0032925440

VL - 83

SP - 6

EP - 10

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -